Pacira BioSciences, Inc. — Director's Dealing 2014

Feb 8, 2014

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2013-12-31

Reporting Person: STACK DAVID M (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-04-16	Common Stock	G	2000	—	Disposed	987	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	18596	Indirect

Footnotes

F1: The shares are held by Stack Schroon Mohawk FLP. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.